Rituximab as induction therapy in pediatric kidney transplantation: A single-center experience in four patients.

Josselin BernardAnne-Laure Sellier-LeclercDelphine DemèdeValérie ChamouardBruno RanchinJustine Bacchetta

Published in: Pediatric transplantation (2022)

The results suggest that rituximab can be used as induction therapy to prevent EBV replication and its complications in case of positive viral load prior to kidney transplantation.

Keyphrases

kidney transplantation
diffuse large b cell lymphoma
end stage renal disease
newly diagnosed
ejection fraction
epstein barr virus
prognostic factors
peritoneal dialysis
stem cells
chronic lymphocytic leukemia
mesenchymal stem cells